Lifecome Biochemistry Co Ltd002868
▼ NegativeCapitalrelevance
Revenue down 15.70% and operating cash flow down 40.08% in interim report.

Lvkang Biochemical released its 2026 interim report on July 31, 2026. The company's total operating revenue was 248 million yuan, down 15.70 percent from the same period last year. Net profit attributable to the parent was 7.316 million yuan. Net cash inflow from operating activities was 45.1667 million yuan, down 40.08 percent year-on-year. The company's latest asset-liability ratio was 90.08 percent, gross margin was 22.89 percent, ROE was 10.31 percent, and diluted earnings per share was 0.05 yuan.
Lifecome Biochemistry Co LtdRevenue down 15.70% and operating cash flow down 40.08% in interim report.